It is not a question of if molecular profiling—the gamut of omics technologies—will enter the clinic, or even when. Clinical omics is happening now. And so, questions about clinical omics are taking a more practical turn, particularly for those who have a professional interest in overseeing, or at least accommodating, omics’ transformation of medicine.

Professionals in the clinic and the laboratory need an information resource that will help them anticipate innovations in treatment and prevention. Mainstream resources are too general, and much of the research literature is too focused on the pioneering of new knowledge, not the consolidation of existing knowledge, that is, the development and standardization of best practices.